Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Strebhardt

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
A fluorescence polarization assay for the discovery of inhibitors of the polo-box domain of polo-like kinase 1Wolfgang Reindl, Klaus Strebhardt, Thorsten Berg
Cancers|June 2, 2021
Targeting CDK9 for Anti-Cancer TherapeuticsRanadip Mandal, Sven Becker, Klaus Strebhardt
Oncogene|January 11, 2005
Polo-like kinases and oncogenesisFrank Eckerdt, Juping Yuan, Klaus Strebhardt
Expert Opinion on Drug Discovery|September 30, 2014
Thoughts on the current assessment of Polo-like kinase inhibitor drug discoveryKlaus Strebhardt, Sven Becker, Yves Matthess
Molecular & Cellular Oncology|December 8, 2018
The role of PLK1 in cancer exhibiting chromosomal instabilityKlaus Strebhardt, Monika Raab, Mourad Sanhaji
Analytical Biochemistry|September 17, 2008
A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1Wolfgang Reindl, Klaus Strebhardt, Thorsten Berg
Anticancer Research|March 14, 2007
The biological relevance of FHL2 in tumour cells and its role as a putative cancer targetKai Kleiber, Klaus Strebhardt, Bernd T Martin
BMC Research Notes|December 8, 2018
Immune adaptor protein SKAP1 (SKAP-55) forms homodimers as mediated by the N-terminal regionMonika Raab, Klaus Strebhardt, Christopher E Rudd
Scientific Reports|July 20, 2019
Immune adaptor SKAP1 acts a scaffold for Polo-like kinase 1 (PLK1) for the optimal cell cycling of T-cellsMonika Raab, Klaus Strebhardt, Christopher E Rudd
Analytical Biochemistry|September 1, 2009
Development of high-throughput assays based on fluorescence polarization for inhibitors of the polo-box domains of polo-like kinases 2 and 3Wolfgang Reindl, Martin Gräber, Klaus Strebhardt, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
A fluorescence polarization assay for the discovery of inhibitors of the polo-box domain of polo-like kinase 1Wolfgang Reindl, Klaus Strebhardt, Thorsten Berg
Cancers|June 2, 2021
Targeting CDK9 for Anti-Cancer TherapeuticsRanadip Mandal, Sven Becker, Klaus Strebhardt
Oncogene|January 11, 2005
Polo-like kinases and oncogenesisFrank Eckerdt, Juping Yuan, Klaus Strebhardt
Expert Opinion on Drug Discovery|September 30, 2014
Thoughts on the current assessment of Polo-like kinase inhibitor drug discoveryKlaus Strebhardt, Sven Becker, Yves Matthess
Molecular & Cellular Oncology|December 8, 2018
The role of PLK1 in cancer exhibiting chromosomal instabilityKlaus Strebhardt, Monika Raab, Mourad Sanhaji
Analytical Biochemistry|September 17, 2008
A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1Wolfgang Reindl, Klaus Strebhardt, Thorsten Berg
Anticancer Research|March 14, 2007
The biological relevance of FHL2 in tumour cells and its role as a putative cancer targetKai Kleiber, Klaus Strebhardt, Bernd T Martin
BMC Research Notes|December 8, 2018
Immune adaptor protein SKAP1 (SKAP-55) forms homodimers as mediated by the N-terminal regionMonika Raab, Klaus Strebhardt, Christopher E Rudd
Scientific Reports|July 20, 2019
Immune adaptor SKAP1 acts a scaffold for Polo-like kinase 1 (PLK1) for the optimal cell cycling of T-cellsMonika Raab, Klaus Strebhardt, Christopher E Rudd
Analytical Biochemistry|September 1, 2009
Development of high-throughput assays based on fluorescence polarization for inhibitors of the polo-box domains of polo-like kinases 2 and 3Wolfgang Reindl, Martin Gräber, Klaus Strebhardt, et al.
Pageof 11